Tissue Repair

BPC-157: Research Overview and Mechanisms of Action

June 2026·8 min read

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a partial sequence of a protective protein identified in human gastric juice. Since its characterization, it has become one of the most extensively referenced compounds in tissue-repair peptide research, with published work spanning gastrointestinal, musculoskeletal, and vascular models.

Studied Mechanisms

Preclinical research has examined several overlapping pathways through which BPC-157 may influence tissue repair:

  • Angiogenesis signalling — studies have looked at BPC-157's interaction with the VEGF (vascular endothelial growth factor) pathway, relevant to new blood vessel formation during healing.
  • Growth factor modulation — research has explored effects on growth-hormone receptor expression and downstream signalling in tendon and ligament fibroblast models.
  • Nitric oxide system interaction — several studies propose an interaction with the NO system, which is implicated in vascular tone and tissue-repair signalling.

Research Models

Much of the published literature on BPC-157 uses in-vitro fibroblast and endothelial cell models, along with rodent models of tendon, ligament, and gastrointestinal injury, to study healing-rate and tissue-integrity endpoints.

Handling in the Lab

BPC-157 is supplied as a lyophilized powder and should be stored at -20°C, protected from light, prior to reconstitution. See our Reconstitution Calculator for solution-concentration math, and our BPC-157 product page for current batch specifications.

Research Use Only. This article is provided for general research and educational context only. It does not constitute medical advice, and none of the compounds discussed are intended for human or veterinary use.